依达拉奉联合单唾液酸四己糖神经节苷脂钠治疗急性脑梗死的临床研究

【摘要】 目的:研究依达拉奉联合单唾液酸四己糖神经节苷脂钠治疗急性脑梗死的临床疗效。方法:随机选出182例急性脑梗死患者随机分为两组,治疗组采用依达拉奉和单唾液酸四己糖神经节苷脂钠分别加入生理盐水中静滴,1次/日,21天1个疗程。对照组采用胞二磷胆碱注射液加入生理盐水中静滴,疗程及用法同治疗组。结果:治疗组基本治愈率(32.97%)、总有效率(85.71%),明显高于对照组基本治愈率(18.68%)、总有效率(65.93%),两者有统计学差异(P<0.05)。结论:早期应用依达拉奉和单唾液酸四己糖神经节苷脂钠治疗急性脑梗死,可加速神经功能的恢复,提高患者的生存质量,改善预后。更多还原

【Abstract】 Objective:To evaluate the curative effect of Edaravone and Monosialotetrahexosy Lganglioside Sodium injection on acute cerebral infarction.Methods:Total 182 patientswith acute cerebral infarction were randomly divided into two group:the treatment group and control group1,The treatment group were treated with Edaravone and Monosialotetrahexosy Lganglioside Sodium injection(everyday for 21 days)and the control group were treated with citicoline(everyday for 21 days).Results:There was significant difference in the total effective rate between the treatment group(85.71%)and the control group(65.93%)(P<0.05).Conclusion:The patients with acute cerebral infarction during the early period should be treated with Edaravone and Monosialotetrahexosy Lganglioside Sodium injection,whichwill speed the recovery of neurological function and imp rove the quality of life.更多还原